Skip to main content

Patient Access

By Adam Ang | 07:13 am | November 24, 2025
Former Zuellig Pharma exec Louis Payet launches Peach Health Asia, aiming to make coach-guided tele-physiotherapy and digital rehabilitation accessible across Southeast Asia.
By Jessica Hagen | 01:36 pm | November 20, 2025
The autoimmune disease-focused platform will integrate Instacart Health Fresh Funds into its care model to provide members with grocery stipends to access healthy foods.
By Jessica Hagen | 04:22 pm | November 19, 2025
During a fireside chat with Scripta Insights’ CEO, Cuban discussed TrumpRx and unveiled new MCCPDC innovations, including mobile drug-making pods and the Cost Plus Wellness network.
By Anthony Vecchione | 02:16 pm | November 19, 2025
Dr. Dee Dee Wang, cardiologist and section head of cardiac imaging at NCH Rooney Heart Institute, joined MobiHealthNews to discuss a new technology that identifies heart disease years before patients present with symptoms.
By Anthony Vecchione | 03:10 pm | November 17, 2025
Sentara will launch Andor Health's virtual health platform ThinkAndor in 1,742 hospital rooms across 12 facilities.
By Bill Siwicki | 02:57 pm | November 17, 2025
Two executives from the St. Louis community health center discuss results of a generative AI pilot designed to enhance interpretation services – extending the reach of multilanguage accessibility to its six FQHCs with large immigrant populations.
By Jessica Hagen | 12:00 pm | November 14, 2025
Carrot’s Sprints members will have access to sleep, stress, activity and glucose data from Oura and Dexcom, along with clinical guidance to support metabolic fertility care.
By HIMSS TV | 10:24 am | November 10, 2025
Tom Gillette, Mount Sinai Medical Center's CIO, discusses how Spanish-language AI, predictive models and remote patient monitoring are boosting patient engagement and care access for its diverse South Florida community.
By Jessica Hagen | 03:01 pm | November 06, 2025
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.
By Mike Miliard | 02:09 pm | November 03, 2025
In the third installment of this three-part series, clinical and IT leaders from the New Jersey health system discuss how its virtual acute care program is now enabling new innovations at its brick-and-mortar hospitals.